BTIG Cuts Stryker (SYK) Price Target to $316

BTIG has maintained its Buy rating on Stryker while lowering the price target to $316 from $358, a 7.37% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:00 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

BTIG cut its price target on Stryker Corporation ($SYK) to $316 from $358 on October 12, 2026, and rates the stock "Buy".

Since the rating, $SYK is up 4.3% to date (from the $282.60 close on Oct 12, 2026).

SYK Stryker Corporation

$294.66 -14.65% year to date

Daily close · Oct 16, 2026

Key Points

On October 12, 2026, BTIG reiterated its Buy rating on Stryker Corporation (NYSE: SYK) with a revised price target of $316, down from $358.
BTIG's $316 price target implies 7.37% upside from Stryker Corporation's ($SYK) current $294.30 share price.
As of October 16, 2026, Stryker's shares were recently trading around $294.30, which is 18.8% below the average analyst price target of $362.62.
Stryker has a P/E ratio of 30.4 and a revenue growth rate of 9.4% year-over-year, indicating solid performance in the medical devices sector.

Get $SYK trade alerts by text

We text you when insiders, Congress or big funds trade $SYK. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stryker Corporation alert may contain errors. Disclosures

BTIG has reiterated its Buy rating on Stryker Corporation (NYSE: SYK) on October 12, 2026, lowering its price target to $316 from $358. This adjustment reflects the firm's ongoing confidence in the company's prospects despite the revision.

Other Institutional Activity in Stryker Corporation

Several other funds have been active with Stryker shares. Blackrock Inc. trimmed its stake by 187,697 shares, leaving it with 27,414,742 shares valued at approximately $8.08 billion. Vanguard Capital Management LLC added 154,439 shares, increasing its total to 22,536,843 shares worth about $6.64 billion. JPMorgan Chase & Co. also increased its holdings, gaining 1,664,175 shares for a total of 17,260,943 shares valued at around $5.09 billion. State Street Corporation raised its position by 182,664 shares, totaling 15,532,565 shares worth about $4.58 billion. Meanwhile, Greenleaf Trust reduced its holdings by 709,231 shares, ending with 15,228,545 shares worth approximately $4.49 billion.

Stryker Corporation Stock Up 4.5%

As of October 16, 2026, Stryker's stock was recently trading around $294.30, which is below its 50-day moving average of $300.80 and its 200-day moving average of $326.94. The shares are also 25% below their 52-week high of $392.55, while remaining 10.2% above their 52-week low of $267.00. This positioning indicates challenges in the market as the stock is trading below key moving averages and the mean analyst price target.

12-month forecast

$SYK price target

Stryker Corporation daily closes and this analyst's $316 target. Not advice.

Recent Earnings

Stryker reported trailing twelve-month revenue of approximately $25.83 billion, with earnings per share (EPS) of $9.65. The company achieved a net margin of 14.4% and a return on equity (ROE) of 16.5%. The next earnings report is scheduled for October 29, 2026.

Dividend

Stryker pays an annual dividend yielding 1.2%, with a payout ratio of 36.1%.

Insider Buying and Selling at Stryker Corporation

Several insiders have sold shares recently. Robert S. Fletcher, an Officer, sold 4,544 shares, totaling about $1.39 million on May 28, 2026. Debra King, also an Officer, sold 826 shares for approximately $277,787 on August 18, 2026, while Ronda E. Stryker, a Director, sold 350,000 shares valued at about $117.78 million on August 19, 2026. Dylan Bram Crotty, another Officer, sold 441 shares for around $144,915 on August 21, 2026.

Analysts Set New Price Targets

On October 12, 2026, BTIG maintained its Buy rating on Stryker with a revised price target of $316. Earlier, on September 22, 2026, TD Cowen maintained a Hold rating with a target of $298, while Stifel kept a Buy rating with a target of $330 on September 30, 2026. Truist Securities also maintained its Hold rating with a target of $310 on October 7, 2026. The consensus among analysts indicates a mean price target of $362.62 based on 26 opinions.

About Stryker Corporation

Stryker Corporation is a medical technology company based in Portage, Michigan. It operates in the healthcare sector, focusing on medical devices through segments like MedSurg and Neurotechnology, as well as Orthopaedics. The company's innovative solutions are pivotal in improving surgical outcomes and patient care, making the recent analyst updates particularly relevant.

Bottom Line

Investors should keep an eye on Stryker's upcoming earnings report on October 29, 2026, as well as any further updates from analysts regarding price targets and ratings. The adjustments from BTIG and other firms suggest a cautious outlook in the current market environment.